首页> 外文OA文献 >Low Temperature Plasma : A Novel Focal Therapy for Localized Prostate Cancer?
【2h】

Low Temperature Plasma : A Novel Focal Therapy for Localized Prostate Cancer?

机译:低温血浆:局部前列腺癌的新型局灶疗法?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite considerable advances in recent years for the focal treatment of localized prostate cancer, high recurrence rates and detrimental side effects are still a cause for concern. In this review, we compare current focal therapies to a potentially novel approach for the treatment of early onset prostate cancer: low temperature plasma. The rapidly evolving plasma technology has the potential to deliver a wide range of promising medical applications via the delivery of plasma-induced reactive oxygen and nitrogen species. Studies assessing the effect of low temperature plasma on cell lines and xenografts have demonstrated DNA damage leading to apoptosis and reduction in cell viability. However, there have been no studies on prostate cancer, which is an obvious candidate for this novel therapy. We present here the potential of low temperature plasma as a focal therapy for prostate cancer.
机译:尽管近年来用于局限性前列腺癌的局部治疗取得了很大进展,但是高复发率和有害副作用仍然令人关注。在这篇综述中,我们将当前的局部疗法与一种可能的新颖方法用于治疗早发性前列腺癌:低温血浆。迅速发展的等离子体技术有潜力通过输送等离子体诱导的活性氧和氮来提供广泛的有前途的医学应用。评估低温血浆对细胞系和异种移植物影响的研究表明,DNA损伤会导致细胞凋亡并降低细胞活力。然而,还没有关于前列腺癌的研究,前列腺癌显然是这种新疗法的候选者。我们在这里介绍低温血浆作为前列腺癌的焦点疗法的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号